Anna joined Novo Ventures (US) Inc. in San Francisco, California in 2017.
Prior to joining Novo Ventures (US) Inc., Anna was responsible for covering large and smid cap biotech companies at Sectoral Asset Management. Previously, she was an associate at a boutique financial advisory firm in Montreal, where she worked on financing transactions in the life science industry.
Anna received a Ph.D. and B.Sc. in Biochemistry, both from McGill University. She is also a CFA charterholder.